Borrego Dialysis Llc in Cincinnati, Ohio - Dialysis Center

Borrego Dialysis Llc is a medicare approved dialysis facility center in Cincinnati, Ohio and it has 15 dialysis stations. It is located in Hamilton county at 6909 Good Samaritan Dr. Suite C, Cincinnati, OH, 45247. You can reach out to the office of Borrego Dialysis Llc at (513) 353-0237. This dialysis clinic is managed and/or owned by Davita. Borrego Dialysis Llc has the following ownership type - Profit. It was first certified by medicare in November, 2016. The medicare id for this facility is 362849 and it accepts patients under medicare ESRD program.

Name	Borrego Dialysis Llc
Location	6909 Good Samaritan Dr. Suite C, Cincinnati, Ohio
No. of Dialysis Stations	15
Medicare ID	362849
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Borrego Dialysis Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1881050292
Organization Name	Western Ridge Dialysis
Doing Business As	Borrego Dialysis Llc
Address	6909 Good Samaritan Dr Cincinnati, Ohio, 45247
Phone Number	(513) 353-0237

Dialysis patients with Hemoglobin data

5

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	12
  Adult patient months included in Kt/V greater than or equal to 1.2	79
  Percentage of adult patients getting regular hemodialysis at the center	92
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Borrego Dialysis Llc with elevated calcium levels.

Patients with hypercalcemia	12
Hypercalcemia patient months	79
Patients with Serumphosphor	12
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	35
Patients with Serumphosphor from 5.6 to 7 mg/dL	28
Patients with Serumphosphor greater than 7 mg/dL	5

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	20
Patient months included in arterial venous fistula and catheter summaries	74
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	78
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	1

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	1
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit